Mark Stout

1.1k citations

19 papers · 824 indexed · h-index 14

Impact in

Hematology top 5%
- Acute Myeloid Leukemia Research
Rheumatology top 5%
- Folate and B Vitamins Research

Papers in

Hematology 6
- Acute Myeloid Leukemia Research 6
Rheumatology 6
- Folate and B Vitamins Research 6

Co-authors: Larry H. Matherly Yaddanapudi Ravindranath Jeffrey W. Taub Steven Buck Yubin Ge Sita Kugel Desmoulin Gita Massey Süreyya Savaşan
Journals: Blood (3 papers)Molecular Pharmacology (3 papers)Cancer Research (2 papers)JNCI Journal of the National Cancer Institute (1 paper)Clinical Cancer Research (1 paper)
Partner nations: United States China Czechia

In The Last Decade

Mark Stout

19 papers receiving 818 citations

Peers

Countries citing papers authored by Mark Stout

Since Specialization

Citations

This map shows the geographic impact of Mark Stout's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Stout with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Stout more than expected).

Fields of papers citing papers by Mark Stout

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark Stout. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Stout. The network helps show where Mark Stout may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Mark Stout, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Mark Stout Line = papers co-authored together Mark Stout links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

#	Work
1	Therapeutic targeting malignant mesothelioma with a novel 6-substituted pyrrolo[2,3-d]pyrimidine thienoyl antifolate via its selective uptake by the proton-coupled folate transporter Cancer Chemotherapy and Pharmacology ·Christina Cherian, Sita Kugel Desmoulin, Lei Wang, Lisa Polin, Kathryn White, Juiwanna Kushner, Mark Stout, Zhanjun Hou, Aleem Gangjee, Larry H. Matherly	2013	20
2	Functional Loss of the Reduced Folate Carrier Enhances the Antitumor Activities of Novel Antifolates with Selective Uptake by the Proton-Coupled Folate Transporter Molecular Pharmacology ·Sita Kugel Desmoulin, Lei Wang, Lisa Polin, Kathryn White, Juiwanna Kushner, Mark Stout, Zhanjun Hou, Christina Cherian, Aleem Gangjee, Larry H. Matherly	2012	27
3	Therapeutic Targeting of a Novel 6-Substituted Pyrrolo [2,3-d]pyrimidine Thienoyl Antifolate to Human Solid Tumors Based on Selective Uptake by the Proton-Coupled Folate Transporter Molecular Pharmacology ·Sita Kugel Desmoulin, Lei Wang, Igor Aleksandrovich Viktorov, Lisa Polin, Kathryn White, Juiwanna Kushner, Mark Stout, Zhanjun Hou, Christina Cherian, Aleem Gangjee, Larry H. Matherly	2011	57
4	Synthesis, Biological, and Antitumor Activity of a Highly Potent 6-Substituted Pyrrolo[2,3-d]pyrimidine Thienoyl Antifolate Inhibitor with Proton-Coupled Folate Transporter and Folate Receptor Selectivity over the Reduced Folate Carrier That Inhibits β-Glycinamide Ribonucleotide Formyltransferase Journal of Medicinal Chemistry ·Lei Wang, Sita Kugel Desmoulin, Christina Cherian, Lisa Polin, Kathryn White, Juiwanna Kushner, 有花成田, Min‐Hwang Chang, Nouf Binhowaimel, Mark Stout, Michael F. Romero, Zhanjun Hou, Larry H. Matherly, Aleem Gangjee	2011	61
5	Targeting the Proton-Coupled Folate Transporter for Selective Delivery of 6-Substituted Pyrrolo[2,3-d]Pyrimidine Antifolate Inhibitors of De Novo Purine Biosynthesis in the Chemotherapy of Solid Tumors Molecular Pharmacology ·Sita Kugel Desmoulin, Yiqiang Wang, Jianmei Wu, Mark Stout, Zhanjun Hou, 有花成田, Min‐Hwang Chang, Michael F. Romero, Christina Cherian, Aleem Gangjee, Larry H. Matherly	2010	51
6	Mechanisms of Synergistic Antileukemic Interactions between Valproic Acid and Cytarabine in Pediatric Acute Myeloid Leukemia Clinical Cancer Research ·Chengzhi Xie, Holly Edwards, Xuelian Xu, Hui Zhou, Steven Buck, Mark Stout, Qun Yu, Jeffrey E. Rubnitz, Larry H. Matherly, Jeffrey W. Taub, Yubin Ge	2010	71
7	Synergistic Antileukemic Interactions Between Valproic Acid and Cytarabine: A Potential Means to Improve the Treatment of Pediatric Acute Myeloid Leukemia. Blood ·Chengzhi Xie, Holly Edwards, Lisa Polin, Hui Zhou, Hamed Haderbache, J. Dilulio, Natarajan Parathesia PILLAI, Steven Buck, Mark Stout, Jeffrey E. Rubnitz, Larry H. Matherly, Jeffrey W. Taub, Qun Yu, Yubin Ge	2009	1
8	Melatonin cytotoxicity in human leukemia cells: relation with its pro‐oxidant effect Fundamental and Clinical Pharmacology ·Mustafa Büyükavcı, Öner Özdemır, Steven Buck, Mark Stout, Yaddanapudi Ravindranath, Süreyya Savaşan	2006	84
9	GATA1, Cytidine Deaminase, and the High Cure Rate of Down Syndrome Children With Acute Megakaryocytic Leukemia JNCI Journal of the National Cancer Institute ·Yubin Ge, Mark Stout, Naomi Christensen, Tore Jensen, Stephen H. Buck, R. L. Thomas, Y. Ravindranath, Larry H. Matherly, Jeffrey W. Taub	2005	82
10	Differential gene expression, GATA1 target genes, and the chemotherapy sensitivity of Down syndrome megakaryocytic leukemia Blood ·Yubin Ge, Alan A. Dombkowski, Katherine M. LaFiura, Naomi Christensen, Ravikiran S. Yedidi, Mark Stout, Steven Buck, Gita Massey, David L. Becton, Howard J. Weinstein, Yaddanapudi Ravindranath, Larry H. Matherly, Jeffrey W. Taub	2005	81
11	Increased generation of reactive oxygen species correlates with cytotoxicty in Acute Myeloid Leukemia (AML) of Down Syndrome and is augmented by cytotoxic agents affecting the mitochondrial electron transport chain. Cancer Research ·Mohr, Steven Buck, Robert M. Johnson, Mark Stout, Yaddanapudi Ravindranath	2004	2
12	The Role of Cytidine Deaminase and GATA1 Mutations in the Increased Cytosine Arabinoside Sensitivity of Down Syndrome Myeloblasts and Leukemia Cell Lines Cancer Research ·Yubin Ge, میلاد جلیل پیران, Mark Stout, Robin M. Flatley, Patrick J. Grohar, Yaddanapudi Ravindranath, Larry H. Matherly, Jeffrey W. Taub	2004	54
13	Degradation of vincristine by myeloperoxidase and hypochlorous acid in children with acute lymphoblastic leukemia Leukemia Research ·Ünsal Özgen, Yusuf Türköz, Mark Stout, Fikret Özuğurlu, Zong-zhou Wu, Marc V Jaramillo, Mehmet Aslan, Yaddanapudi Ravindranath, Süreyya Savaşan	2003	11
14	Further elucidation of mechanism of resistance to vincristine in myeloid cells: role of hypochlorous acid in degradation of vincristine by myeloperoxidase Leukemia ·Ünsal Özgen, Süreyya Savaşan, Mark Stout, Steven Buck, Yaddanapudi Ravindranath	2000	20
15	Cystathionine-beta-synthase cDNA transfection alters the sensitivity and metabolism of 1-beta-D-arabinofuranosylcytosine in CCRF-CEM leukemia cells in vitro and in vivo: a model of leukemia in Down syndrome. PubMed ·Jeffrey W. Taub, Xi Huang, Yubin Ge, Julie Dutcher, Mark Stout, Ramzi M. Mohammad, Yaddanapudi Ravindranath, Larry H. Matherly	2000	30
16	Expression of chromosome 21-localized genes in acute myeloid leukemia: differences between Down syndrome and non-Down syndrome blast cells and relationship to in vitro sensitivity to cytosine arabinoside and daunorubicin. Blood ·Jeffrey W. Taub, Xi Huang, Larry H. Matherly, Mark Stout, Steven Buck, Gita Massey, David L. Becton, Myron Chang, Howard J. Weinstein, Yaddanapudi Ravindranath	1999	123
17	Alkylsulphonic acid ion pairing with radial compression columns for determining plasma or cerebrospinal fluid 1-β-d-arabinofuranosylcytosine in pediatric pharmacokinetic analysis Journal of Chromatography A ·Mark Stout, Y. Ravindranath	1995	5
18	Follicular fluid concentrations of thiopental and thiamylal during laparoscopy for oocyte retrieval Fertility and Sterility ·Sara Hernández Martín, Mark Stout, David M. Magyar, Maria F. Hayes, Kamran S. Moghissi, Anthony G. Sacco	1987	31
19	High-performance liquid chromatographic assay for methotrexate utilizing a cold acetonitrile purification and separation of plasma or cerebrospinal fluid Journal of Chromatography B Biomedical Sciences and Applications ·Mark Stout, Y. Ravindranath, Ralph E. Kauffman	1985	13

About Mark Stout

Mark Stout is a scholar working on Hematology, Rheumatology, Molecular Biology, Infectious Diseases and Endocrine and Autonomic Systems, having authored 19 papers that have together received 824 indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (6 papers), Folate and B Vitamins Research (6 papers), Biochemical and Molecular Research (4 papers), Acute Lymphoblastic Leukemia research (4 papers), Histone Deacetylase Inhibitors Research (3 papers), HIV/AIDS drug development and treatment (3 papers), Epigenetics and DNA Methylation (2 papers) and Neutrophil, Myeloperoxidase and Oxidative Mechanisms (2 papers). The work is most often cited by research in Hematology (318 citations), Rheumatology (184 citations), Endocrine and Autonomic Systems (65 citations), Public Health, Environmental and Occupational Health (205 citations) and Biochemistry (50 citations). Mark Stout has collaborated with scholars based in United States, China and Czechia. Frequent co-authors include Larry H. Matherly, Yaddanapudi Ravindranath, Jeffrey W. Taub, Steven Buck, Yubin Ge, Sita Kugel Desmoulin, Gita Massey, Süreyya Savaşan, Zhanjun Hou and Aleem Gangjee. Their work appears in journals such as Blood, Molecular Pharmacology, Cancer Research, JNCI Journal of the National Cancer Institute and Clinical Cancer Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact